Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPSAB1 | Q15661 | 8/20 | 0.53 |
| ▸ | TPSD1 | Q9BZJ3 | 8/20 | 0.53 |
| ▸ | TPSG1 | Q9NRR2 | 8/20 | 0.53 |
| ▸ | F2 | P00734 | 7/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8904674 | 1.00 | TPSAB1 (0.53) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8904590 | 0.91 | TPSAB1 (0.53) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8712942 | 0.91 | TPSAB1 (0.53) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8716704 | 0.87 | F2 (0.55) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8904670 | 0.87 | F2 (0.55) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8903361 | 0.86 | F2 (0.51) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8905120 | 0.86 | ITGB3 (0.47) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8712867 | 0.86 | F2 (0.51) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8715707 | 0.86 | ITGB3 (0.47) | TPSAB1TPSD1TPSG1F2ITGB3 | |
| SCHEMBL8904684 | 0.84 | ITGB3 (0.40) | TPSAB1TPSD1TPSG1F2ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5753670-A | ANTICOAGULANTS | THE GREEN CROSS CORPORATION (JP) | 1998-05-19 | — | — | US | disclosed |
| US-5635527-A | ANTAGONIST OF PLATELET MEMBRANE GLYCOPROTEIN; TREATMENT OF THROMBOTIC DISEASES | THE GREEN CROSS CORPORATION (JP) | 1997-06-03 | — | — | US | disclosed |
| EP-0712844-A1 | NOVEL FUSED-RING CARBOXYLIC ACID COMPOUND OR SALT THEREOF, AND MEDICINAL USE THEREOF | THE GREEN CROSS CORPORATION (JP) | 1996-05-22 | — | — | EP | disclosed |